Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 4:11 PM View:  | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 11-Apr-24 | Grant | 32,000 | -- | -- | 30% 107.31K to 139.31K | |
| 25-Mar-24 4:44 PM View: | Schachle Joseph K Chief Operating Officer | Ocuphire Pharma, Inc. (OCUP) | 21-Mar-24 | Private Purchase | 2,000 | $2.05 | $4,100.00 | 100% 0 to 2.0K | |
| 25-Mar-24 4:40 PM View: | Jhaveri Nirav S. Chief Financial Officer | Ocuphire Pharma, Inc. (OCUP) | 21-Mar-24 | Private Purchase | 10,000 | $2.10 | $21,000.00 | 7% 140.0K to 150.0K | |
| 20-Mar-24 4:18 PM View: | Magrath George Chief Executive Officer | Ocuphire Pharma, Inc. (OCUP) | 18-Mar-24 | Private Purchase | 25,000 | $1.96 | $49,050.00 | 6% 400.0K to 425.0K | |
| 14-Feb-24 6:37 PM View: | Jhaveri Nirav S. Chief Financial Officer | Ocuphire Pharma, Inc. (OCUP) | 12-Feb-24 | Grant | 140,000 | -- | -- | 100% 0 to 140.0K | |
| 14-Feb-24 6:35 PM View: | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Ocuphire Pharma, Inc. (OCUP) | 12-Feb-24 | Grant | 75,000 | -- | -- | 100% 0 to 75.0K | |
| 22-Jan-24 6:01 PM View: | Zaremba Rabourn Amy SVP of Finance | Ocuphire Pharma, Inc. (OCUP) | 18-Jan-24 | Grant | 40,000 | -- | -- | 94% 42.66K to 82.66K | |
| 22-Jan-24 6:01 PM View: | Hoffmann Bernhard SVP of Corp. Dev. | Ocuphire Pharma, Inc. (OCUP) | 18-Jan-24 | Grant | 20,000 | -- | -- | 14% 142.7K to 162.7K | |
| 12-Jan-24 4:17 PM View: | Zaremba Rabourn Amy SVP of Finance | Ocuphire Pharma, Inc. (OCUP) | 10-Jan-24 | Payment of Exercise | 3,950 | $3.27 | $12,896.80 | (8%) 46.61K to 42.66K | (9%) |
| 12-Jan-24 4:17 PM View: | Hoffmann Bernhard SVP of Corp. Dev. | Ocuphire Pharma, Inc. (OCUP) | 10-Jan-24 | Payment of Exercise | 4,031 | $3.27 | $13,161.20 | (3%) 146.73K to 142.7K | (9%) |
| 12-Jan-24 4:17 PM View: | Patel Ronil A. Chief Business Officer | Ocuphire Pharma, Inc. (OCUP) | 10-Jan-24 | Payment of Exercise | 1,282 | $3.27 | $4,185.73 | (1%) 92.0K to 90.71K | (9%) |
| 03-Jan-24 6:06 PM View: | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jan-24 | Grant | 14,964 | -- | -- | 16% 92.35K to 107.31K | |
| 03-Jan-24 5:57 PM View: | Benton Susan Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jan-24 | Grant | 19,418 | -- | -- | 24% 79.46K to 98.88K | |
| 03-Jan-24 6:04 PM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jan-24 | Grant | 22,090 | -- | -- | 32% 68.8K to 90.89K | |
| 03-Jan-24 6:03 PM View: | Rodgers Richard J Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jan-24 | Grant | 24,762 | -- | -- | 14% 173.25K to 198.01K | |
| 05-Dec-23 4:30 PM View: | Patel Ronil A. Chief Business Officer | Ocuphire Pharma, Inc. (OCUP) | 01-Dec-23 | Grant | 49,692 | -- | -- | 117% 42.3K to 92.0K | |
| 13-Nov-23 5:42 PM View: | Rodgers Richard J Director | Ocuphire Pharma, Inc. (OCUP) | 01-Nov-23 | Grant | 35,000 | -- | -- | 25% 138.25K to 173.25K | |
| 13-Nov-23 5:46 PM View: | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 01-Nov-23 | Grant | 35,000 | -- | -- | 61% 57.35K to 92.35K | |
| 03-Nov-23 9:29 AM View: | Magrath George Chief Executive Officer | Ocuphire Pharma, Inc. (OCUP) | 01-Nov-23 | Grant | 400,000 | -- | -- | 100% 0 to 400.0K | |
| 08-Jun-23 6:48 PM View: | Gallagher Cam Director | Ocuphire Pharma, Inc. (OCUP) | 06-Jun-23 | Grant | 10,976 | -- | -- | 44% 24.93K to 35.9K | |
| 08-Jun-23 6:49 PM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 06-Jun-23 | Grant | 10,976 | -- | -- | 19% 57.83K to 68.8K | |
| 08-Jun-23 6:49 PM View: | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 06-Jun-23 | Grant | 10,976 | -- | -- | 24% 46.38K to 57.35K | |
| 08-Jun-23 6:49 PM View: | Ainsworth Sean Director | Ocuphire Pharma, Inc. (OCUP) | 06-Jun-23 | Grant | 10,976 | -- | -- | 30% 36.24K to 47.22K | |
| 08-Jun-23 6:48 PM View: | Benton Susan Director | Ocuphire Pharma, Inc. (OCUP) | 06-Jun-23 | Grant | 10,976 | -- | -- | 16% 68.49K to 79.46K | |
| 26-Apr-23 9:25 PM View: | Patel Ronil A. SVP, Operations & Bus. Dev. | Ocuphire Pharma, Inc. (OCUP) | 24-Apr-23 | Grant | 20,000 | -- | -- | 90% 22.3K to 42.3K | |
| 21-Apr-23 8:20 PM View: | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 19-Apr-23 | Grant | 468 | -- | -- | 1% 45.91K to 46.38K | |
| 21-Apr-23 8:20 PM View: | Rodgers Richard J Interim CEO and President Director | Ocuphire Pharma, Inc. (OCUP) | 19-Apr-23 | Grant | 50,000 | -- | -- | 57% 88.25K to 138.25K | |
| 21-Apr-23 8:20 PM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 19-Apr-23 | Grant | 2,819 | -- | -- | 5% 55.01K to 57.83K | |
| 21-Apr-23 8:20 PM View: | Benton Susan Director | Ocuphire Pharma, Inc. (OCUP) | 19-Apr-23 | Grant | 1,053 | -- | -- | 2% 67.43K to 68.49K | |
| 12-Jan-23 5:28 PM View: | Benton Susan Director | Ocuphire Pharma, Inc. (OCUP) | 11-Jan-23 | Grant | 16,267 | -- | -- | 32% 51.17K to 67.43K | |
| 12-Jan-23 5:34 PM View: | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 11-Jan-23 | Grant | 13,013 | -- | -- | 40% 32.89K to 45.91K | |
| 12-Jan-23 5:34 PM View: | Rodgers Richard J Director | Ocuphire Pharma, Inc. (OCUP) | 11-Jan-23 | Grant | 20,822 | -- | -- | 31% 67.42K to 88.25K | |
| 12-Jan-23 5:37 PM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 11-Jan-23 | Grant | 18,544 | -- | -- | 51% 36.47K to 55.01K | |
| 12-Jan-23 6:08 PM View: | Sooch Mina President and CEO Director | Ocuphire Pharma, Inc. (OCUP) | 10-Jan-23 | Grant | 134,456 | -- | -- | 39% 346.05K to 480.5K | |
| 12-Jan-23 5:30 PM View: | Zaremba Rabourn Amy SVP of Finance | Ocuphire Pharma, Inc. (OCUP) | 10-Jan-23 | Grant | 46,608 | -- | -- | 100% 0 to 46.61K | |
| 12-Jan-23 5:33 PM View: | Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. | Ocuphire Pharma, Inc. (OCUP) | 10-Jan-23 | Grant | 46,608 | -- | -- | 47% 100.12K to 146.73K | |
| 06-Jan-23 9:00 AM View: | Gallagher Cam Director | Ocuphire Pharma, Inc. (OCUP) | 04-Jan-23 | Exercise (in-the money or at-the-money) | 1,574 | $0.00 | $0.16 | 7% 23.35K to 24.93K | |
| 14-Feb-23 10:00 PM View: | Sooch Mina President and CEO Director | Ocuphire Pharma, Inc. (OCUP) | 27-Dec-22 | Gift | 50,000 | -- | -- | 13% 396.05K to 446.05K | |
| 14-Feb-23 10:00 PM View: | Sooch Mina President and CEO Director | Ocuphire Pharma, Inc. (OCUP) | 27-Dec-22 | Gift | 100,000 | -- | -- | (22%) 446.05K to 346.05K | |
| 14-Feb-23 10:00 PM View: | Sooch Mina President and CEO Director | Ocuphire Pharma, Inc. (OCUP) | 23-Dec-22 | Gift | 30,000 | -- | -- | (7%) 426.05K to 396.05K | |
| 20-Oct-22 4:01 PM View: | Ainsworth Sean Director | Ocuphire Pharma, Inc. (OCUP) | 19-Oct-22 | Exercise (in-the money or at-the-money) | 1,574 | $0.00 | $0.16 | 4% 39.66K to 41.24K | |
| 12-Oct-22 4:23 PM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 11-Oct-22 | Exercise (in-the money or at-the-money) | 787 | $0.00 | $0.08 | 2% 35.68K to 36.47K | |
| 04-Oct-22 9:00 AM View: | Rodgers Richard J Director | Ocuphire Pharma, Inc. (OCUP) | 03-Oct-22 | Exercise (in-the money or at-the-money) | 3,148 | $0.00 | $0.31 | 5% 64.28K to 67.42K | |
| 08-Sep-22 4:01 PM View: | Sooch Mina President and CEO Director | Ocuphire Pharma, Inc. (OCUP) | 06-Sep-22 | Exercise (in-the money or at-the-money) | 1,023 | $0.00 | $0.10 | < 1% 425.02K to 426.05K | |
| 06-Jul-22 5:36 PM View: | Pepose Jay Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jul-22 | Grant | 9,900 | -- | -- | 43% 22.99K to 32.89K | |
| 06-Jul-22 5:58 PM View: | Rodgers Richard J Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jul-22 | Grant | 23,653 | -- | -- | 58% 40.62K to 64.28K | |
| 06-Jul-22 5:48 PM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jul-22 | Grant | 14,108 | -- | -- | 65% 21.57K to 35.68K | |
| 06-Jul-22 6:07 PM View: | Benton Susan Director | Ocuphire Pharma, Inc. (OCUP) | 01-Jul-22 | Grant | 18,711 | -- | -- | 58% 32.45K to 51.17K | |
| 23-May-22 4:58 PM View: | Sooch Mina President and CEO Director | Ocuphire Pharma, Inc. (OCUP) | 20-May-22 | Purchase | 12,500 | $2.02 | $25,300.00 | 3% 412.52K to 425.02K | |
| 24-May-22 9:43 AM View: | Manuso James S J Director | Ocuphire Pharma, Inc. (OCUP) | 20-May-22 | Private Purchase | 5,000 | $1.99 | $9,950.00 | 30% 16.57K to 21.57K |
